Abstract:The aims of this research were to constitute and evaluate one targeting anticancer co-delivery system for both micro-molecularchemotherapeutic drugs( docetaxel,DTX) and small interfering RNA( siRNA) expressed by COX-2. The nanoparticles composed of poly( D, L-lactide-co-glycolide)( PLGA) bearing disulfide-linkaged reducible polyethyleneimine( PEIss) covered by hyaluronic acid( HA). Meanwhile,HA-PEI-PLGA nanoparticles were prepared as control. Firstly, the solvent evaporation was used to the particles which exhibited a core-shell structure with a uniform size of 150-200 nm. The cumulative drug release in two kinds of PBS media( p H 7. 4 and p H 5. 0) during 72 hours indicated that DTX-loaded nanoparticles had sustained-release effect within 24 hours.The cumulative release of DTX of HRPSP NPs in PBS p H 5. 0 was 10%-25% more than that in PBS p H 7. 4,which demonstrated that favored release of DTX from nanoparticles could be achieved in acidic tumor microenvironment. Then,the highest transfection efficiency was observed after 14-16 h incubation at N / P ratio of 40 /1.Following the saturation of CD44 receptor, the mean fluorescence intensity of HRPSP NPs from the cells decreased drastically in the case of saturation with free HA before. However,there existed no significance in the fluorescence of RPSP NPs between the cells with and without saturation with free HA,which indicated the nanoparticles’ targeting potential toward tumor cells. In the Western blot,the relative silencing efficiency of Bcl-2,bax,capase-3 and COX-2 mRNAprotein was calculated. In comparison to the control group, the silence efficiencies of bax and capase-3 were both significantly increased while that of Bcl-2 was evidently reduced,particularly in siCOX-2 / HRPSP NPs group( P < 0. 01). The similar results were obtained in the silence efficiency of COX-2 protein in which the COX-2 quantity on mRNA and protein decreased. The results suggest that the nanoparticles could achieve the synergistic effect on the combinatorial delivery of siRNA and lipophilic anti-tumor drugs.

Novel Chitosan Derivatives with Reversible Cationization and Hydrophobicization for Tumor Cytoplasm-Specific Burst Co-delivery of Sirna and Chemotherapeutics

Smart Nanoparticles with a Detachable Outer Shell for Maximized Synergistic Antitumor Efficacy of Therapeutics with Varying Physicochemical Properties

A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.

Hyperbranched–hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy

Chitosan Based Ph-Responsive Polymeric Prodrug Vector for Enhanced Tumor Targeted Co-Delivery of Doxorubicin and Sirna.

Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.

Sequential Delivery of Therapeutic Agents Using a Rationally Designed Disulfide-Linked Glycolipid-Like Nanocarrier

Chitosan Coated Ph/redox-Responsive Hyaluronic Acid Micelles for Enhanced Tumor Targeted Co-Delivery of Doxorubicin and Sipd-L1.

Low-density Lipoprotein-Coupled Micelles with Reduction and Ph Dual Sensitivity for Intelligent Co-Delivery of Paclitaxel and Sirna to Breast Tumor

Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor

Precise Engineering of Cholesterol-Loaded Chitosan Micelles As a Promising Nanocarrier System for Co-Delivery Drug-Sirna for the Treatment of Gastric Cancer Therapy

A Ph-Sensitive Micelle for Codelivery of Sirna and Doxorubicin to Hepatoma Cells

GSH/pH Dual-Responsive Supramolecular Hybrid Vesicles for Synergistic Enzymatic/chemo-Tumor Therapy

Pegylated Carboxymethyl Chitosan/Calcium Phosphate Hybrid Anionic Nanoparticles Mediated Htert Sirna Delivery for Anticancer Therapy

Co-delivery of siRNA and docetaxel by hyaluronic acid modified redox-sensitive disulfide-crosslinked nanoparticles

Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy

Polycation-detachable Nanoparticles Self-Assembled from Mpeg-Pcl-g-ss-pdmaema for in Vitro and in Vivo Sirna Delivery.

The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.

Enhanced Therapeutic siRNA to Tumor Cells by a pH-Sensitive Agmatine-Chitosan Bioconjugate.

Bioreducible Cross-Linked Hyaluronic Acid/Calcium Phosphate Hybrid Nanoparticles for Specific Delivery of siRNA in Melanoma Tumor Therapy.

A Supramolecular Co-Delivery Strategy for Combined Breast Cancer Treatment and Metastasis Prevention